ELV
Elevance Health Inc.
$430.92
+5.65
(+1.33%)
Mkt Cap
92.23B
Volume
15,771
52W Range
274.84-436.24
Sector
Healthcare
Beta
0.71
EPS (TTM)
22.50 USD
P/E Ratio
18.90
Revenue (TTM)
201.11B USD
Rev Growth (5Y)
+10.3%
EPS Growth (5Y)
+6.7%
AlphaVal · Fair Value
What we estimate one share is worth
$314.00
Overvalued
moderate signal
35.4% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Stable Earnings Power
68.8 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.
Company Description
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 199.12B | 176.81B | 171.34B | 156.59B | 138.64B | 121.87B | 104.21B | 92.11B | 90.04B | 84.98B | 79.24B | 73.92B |
| Net Income | 5.66B | 5.98B | 5.99B | 5.89B | 6.10B | 4.57B | 4.81B | 3.75B | 3.84B | 2.47B | 2.56B | 2.57B |
| EPS | 25.18 | 25.81 | 25.38 | 24.56 | 25.25 | 18.23 | 18.81 | 14.53 | 14.70 | 9.39 | 9.73 | 9.31 |
| Free Cash Flow | 3.17B | 4.55B | 6.76B | 7.25B | 7.28B | 9.67B | 4.98B | 2.62B | 3.39B | 2.62B | 3.51B | 2.74B |
| FCF / Share | 14.31 | 19.55 | 29.03 | 30.20 | 29.85 | 38.54 | 19.51 | 10.30 | 13.26 | 9.94 | 13.45 | 10.23 |
| Operating CF | 4.29B | 5.81B | 8.06B | 8.40B | 8.36B | 10.69B | 6.06B | 3.83B | 4.18B | 3.20B | 4.12B | 3.37B |
| Total Assets | 121.49B | 116.89B | 108.93B | 102.75B | 97.46B | 88.28B | 78.25B | 72.47B | 71.46B | 66.39B | 63.06B | 62.93B |
| Total Debt | 33.23B | 32.70B | 26.65B | 25.80B | 24.89B | 21.84B | 21.21B | 19.21B | 19.93B | 15.73B | 15.86B | 15.04B |
| Cash & Equiv | 9.49B | 8.29B | 6.53B | 7.39B | 4.88B | 5.74B | 4.94B | 3.93B | 3.61B | 4.08B | 2.11B | 2.15B |
| Book Value | 43.88B | 41.31B | 39.31B | 36.24B | 36.06B | 33.20B | 31.73B | 28.54B | 26.50B | 25.10B | 23.04B | 24.25B |
| Return on Equity | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.14 | 0.15 | 0.13 | 0.14 | 0.10 | 0.11 | 0.11 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.47B | 50.18B | 49.75B | 50.71B | 49.78B | 48.89B | 45.44B | 45.15B | 43.65B | 42.58B | 42.65B | 42.85B |
| Net Income | 1.46B | 1.76B | 547.00M | 1.19B | 1.74B | 2.18B | 418.00M | 1.02B | 2.30B | 2.25B | 856.00M | 1.29B |
| EPS | 6.71 | 8.00 | 2.47 | 5.32 | 7.72 | 9.64 | 1.84 | 4.36 | 9.91 | 9.65 | 3.67 | 5.48 |
| Free Cash Flow | 1.63B | 4.10B | (209.00M) | 775.00M | 1.79B | 821.00M | 384.00M | 2.35B | 124.00M | 1.70B | (3.30B) | 2.29B |
| FCF / Share | 7.46 | 18.59 | -0.94 | 3.43 | 7.91 | 3.63 | 1.69 | 10.06 | 0.53 | 7.30 | -14.15 | 9.75 |
| Operating CF | 1.91B | 4.33B | 84.00M | 1.14B | 2.05B | 1.02B | 706.00M | 2.68B | 447.00M | 1.98B | (2.97B) | 2.61B |
| Total Assets | 126.44B | 125.83B | 121.49B | 122.75B | 121.94B | 119.72B | 116.89B | 116.53B | 112.99B | 111.89B | 108.93B | 110.48B |
| Total Debt | 31.04B | 31.84B | 33.23B | 32.10B | 30.19B | 30.00B | 32.70B | 27.15B | 27.69B | 26.45B | 26.65B | 26.41B |
| Cash & Equiv | 10.23B | 9.66B | 9.49B | 8.71B | 8.56B | 7.50B | 8.29B | 7.87B | 6.50B | 6.23B | 6.53B | 10.92B |
| Book Value | 44.88B | 43.90B | 43.88B | 43.95B | 43.72B | 42.50B | 41.31B | 43.77B | 42.19B | 40.61B | 39.31B | 38.42B |
| Return on Equity | 0.03 | 0.04 | 0.01 | 0.03 | 0.04 | 0.05 | 0.01 | 0.02 | 0.05 | 0.06 | 0.02 | 0.03 |
ELV News
biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV) Head to Head Review
2 Stocks to Buy Hand Over Fist in October
ELV or DHR: Which Is the Better Value Stock Right Now?
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Elevance Health's Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
Elevance Health (NYSE:ELV) Issues FY 2026 Earnings Guidance
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Corient Private Wealth LP Sells 28,940 Shares of Elevance Health, Inc. $ELV
ELV or DHR: Which Is the Better Value Stock Right Now?
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation